Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.20.2
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2020
Stockholders' Equity Note [Abstract]  
Schedule of warrant and stock option grants
    Warrant Grants     Stock Option Grants     Restricted Stock Units  
    Number of shares subject to warrants     Weighted-
average exercise price per share		     Number of shares subject to options     Weighted-
average exercise price per share		     Number of shares subject to restricted stock units     Weighted-
average exercise price per share		  
Balance at December 31, 2019     1,311,916     $ 8.80       338,595     $ 3.94       630,303     $            -  
Granted     100,000       4.80       -       -       2,300,845       -  
Exercised     (584,907 )     5.70       (105,028 )     4.28       (41,667 )     -  
Cancelled/Forfeited     -       -       -       -       (475,000 )     -  
Balance at June 30, 2020     827,009     $ 10.51       233,567     $ 7.16       2,414,481     $ -  
Exercisable at June 30, 2020     827,009     $ 10.51       233,567     $ 7.16       189,500     $ -  
Schedule of stock-based compensation expense categorized of equity components
    For the three months ended     For the six months ended  
    June 30,     June 30,  
    2020     2019     2020     2019  
Stock-based compensation expense   $ 1,988,883     $ 220,540     $ 2,356,547     $ 5,850,373  
Schedule of stock-based compensation expense
    For the three months ended     For the six months ended  
    June 30,     June 30,  
    2020     2019     2020     2019  
Common stock   $ 1,988,883     $ 147,012     $ 2,356,416     $ 404,896  
Stock option awards     -       73,528       -       122,547  
Transfer of common stock by founders to contractors     -       -       -       5,322,930  
Total   $ 1,988,883     $ 220,540     $ 2,356,416     $ 5,850,373